A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005-003680-22

C. Parker; R. Hoskin; S. Pascoe; A. Chodack; Joe O'Sullivan; J.R. Germa; A. Lokna

A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005-003680-22

C. Parker, R. Hoskin, S. Pascoe, A. Chodack, Joe O'Sullivan, J.R. Germa, A. Lokna

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	406-406
Number of pages	1
Journal	EJC SUPPLEMENTS
Volume	7
Publication status	Published - Sept 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{5084578e67c841c6a679253433d9cfbc,

title = "A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005-003680-22",

author = "C. Parker and R. Hoskin and S. Pascoe and A. Chodack and Joe O'Sullivan and J.R. Germa and A. Lokna",

year = "2009",

month = sep,

language = "English",

volume = "7",

pages = "406--406",

journal = "EJC SUPPLEMENTS",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - A double blind, randomised, dose finding, phase II, multicentre study of radium-223 for the treatment of patients with metastatic castration-refractory prostate cancer (CRPC): EudraCT number: 2005-003680-22

AU - Parker, C.

AU - Hoskin, R.

AU - Pascoe, S.

AU - Chodack, A.

AU - O'Sullivan, Joe

AU - Germa, J.R.

AU - Lokna, A.

PY - 2009/9

Y1 - 2009/9

M3 - Article

VL - 7

SP - 406

EP - 406

JO - EJC SUPPLEMENTS

JF - EJC SUPPLEMENTS

ER -